Background: Bone marrow mesenchymal stem cell (BMSC) therapy is a novel approach for treating COPD. However, the difficulty in engraftment and easy clearance of BMSCs in vivo has hindered their clinical application. Hence, exploring effective methods to improve the engraftment and differentiation rates of BMSCs in vivo is urgent. Methods: We constructed BMSCs overexpressing Wnt3a by lentivirus infection and transplanted them into a COPD rat model. The damage level of COPD rat lung tissue was assessed by pathology analysis and inflammatory cytokines analysis. The engraftment of BMSC was detected by immunofluorescence staining. Statistical analysis was performed using GraphPad Prism 7. Results: We found that Wnt3a significantly enhanced the engraftment rate of BMSCs in the lungs of rats and further increased their differentiation rate into type II alveolar epithelial cells. We also assessed the expression of inflammatory factors in the lung tissues of COPD rats and discovered that Wnt3a reduced the levels of the inflammatory factors IL-6 and IL-1β while increasing the level of the anti-inflammatory factor IL-10. Our study demonstrates that Wnt3a can improve the engraftment and differentiation rates of BMSCs in the host and further alleviate COPD symptoms by regulating the secretion of inflammatory factors. Conclusion: Constructing BMSCs overexpressing Wnt3a could serve as a new strategy for stem cell therapy in COPD.
Pulmonary infections are common diseases with high morbidity and mortality. Conventional pathogen detection methods rely on culture and biochemical identification, which are time consuming and limited for undiagnosed cases. Metagenomic next- generation sequencing (mNGS) is a novel detection technology with high sensitivity and unbiased advantages. Most existing studies concentrate on general pulmonary infection cohorts, whereas our study specifically focuses on patients with pulmonary infections of unknown origin. A total of 44 eligible patients hospitalized from January 2018 to December 2019 were included in this retrospective analysis. All specimens were examined by both conventional tests and mNGS. The results revealed that the overall detection rate of mNGS (84.09%, 37/44) was significantly higher than that of conventional methods (61.36%, 27/44; P<0.05). For viruses, fungi and atypical pathogens, mNGS achieved obviously higher detection efficiency (76.92% vs. 38.46% , 90.91% vs. 36.36%, 100% vs. 14.29%, respectively; all P<0.05). In addition, mNGS had a far better capacity to diagnose mixed infections (92.31% vs. 23.08%, P<0.05). Our findings demonstrate that mNGS is well suited for the diagnosis of pulmonary infections with unidentified pathogens. It performs excellently in detecting challenging pathogens and co-infections, and can greatly improve the efficiency of etiological diagnosis for refractory pulmonary infections.